March 1 (Reuters) - Avenue Therapeutics Inc:
* AVENUE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
* Q4 LOSS PER SHARE $0.63 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)
Our Standards: The Thomson Reuters Trust Principles.